Clinical Scorecard: Presbyopia Drops: A Foundation for Future Care
At a Glance
Category
Detail
Condition
Key Mechanisms
Pharmacologic treatments like Qlosi and Vuity that provide temporary relief from near-vision loss.
Target Population
Care Setting
Key Highlights
Presbyopia drops serve as a strategic entry point into long-term eye care.
Customizable dosing regimens empower patients and enhance engagement.
Early positive experiences with drops influence future care decisions.
Clear communication and expectation management are critical for success.
Patients who start with drops are more likely to opt for premium IOLs when cataracts develop.
Patient education on the progressive nature of presbyopia is essential.
Guideline-Based Recommendations
Diagnosis
Management
Offer presbyopia drops as a non-surgical alternative to glasses.
Schedule follow-up visits at 1 month and 3 months to assess patient satisfaction and adaptation.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Drops like Qlosi and Vuity can be used once or twice daily, providing flexibility based on lifestyle. Consideration for post-LASIK patients is also important.
Clinical Best Practices
Educate patients on the nature of presbyopia and the role of drops.
Set realistic expectations regarding the adaptation period and effectiveness.
Foster a partnership approach to care, emphasizing ongoing engagement.
Monitor for side effects or adverse reactions to the drops.
